Cambridge, the tPHL, Cambridge and the tPHL, St George's Hospital, London SUMMARY The first case of disseminated toxoplasmosis following cardiac transplantation in the UK is described, with details of Toxoplasma antibody tests made on other cardiac transplant patients. Sixteen of 40 (39%) of recipients had Toxoplasma antibody before operation. Eleven of 30 (37%) of donors had Toxoplasma antibody. The were four occasions when a negative recipient received a heart from a positive donor. Three survived the immediate postoperative period and two became infected with toxoplasmosis. The implications of this are discussed.
Disseminated toxoplasmosis has been described in immunocompromised hosts after transplantation of the heart,' liver,2 and kidney. rejection and a short course of methylprednisolone and antithymocyte globulin was given. The effectiveness of this therapy was confirmed by a further myocardial biopsy on the 31st day. In the hope of relieving the signs of right heart failure and improving renal function a tricuspid annuloplasty was performed. However, the patient's condition deteriorated and he died 12 days later.
Material and methods

HISTOPATHOLOGY
Histopathological material consisted of the patient's own heart, biopsies taken at five different times from the donor heart, and the postmortem performed 43 days after the transplant operation. At each myocardial biopsy session three separate biopsies were taken. The first was put into OCT medium and after frozen sections had been cut and examined the specimen was unfrozen and fixed in formol saline. The other two specimens were fixed straight away in formol saline. All three specimens were paraffin processed and the short serial sets of sections stained with haematoxylin, phloxin and saffron (HPS) methyl green and pyronin and Masson's trichrome.
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McGregor, Fleck, Nagington, Stovin, Cory-Pearce, English The recipient's original heart weighed 454 g and contained a band of organised thrombus on the lateral wall of the right atrium close to the surface of resection. The tricuspid valve annulus and right ventricle were dilated with a mild degree of hypertrophy of the right ventricular wall which was 6 mm thick at the anterior wall of the conus. The mitral valve was normal. The left ventricle showed asymmetrical hypertrophy being 1*4 cm thick laterally and 2-3 cm thick in the interventricular septum and inferior wall. Microscopical examination showed interstitial fibrosis, multidirectional fibres and hypertrophy confirming the diagnosis of asymmetrical cardiomyopathy, as described by other workers.78 In addition multiple endocardial small papillomata were seen in both ventricles, more frequently in the right than in the left.
The second right ventricular endomyocardial biopsy taken on the 20th post-transplant day showed the presence of Toxoplasma parasites within two heart muscle cells (Fig. 1) . The first posttransplant biopsy and the biopsy from the donor ventricle at the time of replacement of the heart had both been normal. Subsequent biopsies also showed the toxoplasma parasites on the 28th but not on the 31st postoperative days. An interesting feature of the biopsies was the apparent replacement of individual muscle cells by fibrous tissue (Fig. 2) suggestive of past damage by the parasite.
At necropsy on the 43rd post-transplant day toxoplasma was seen in the donor heart but not in the residual recipient atria, in the rectus abdominis, intercostal, pectoral, sternamastoid, diaphragmatic, lingual and oesophagopharyngeal muscles, in the liver and a few in the brain. Toxoplasma organisms were isolated from the cardiac muscle at postmortem by inoculation into mice. SEROLOGY Toxoplasma antibodies were measured using the dye test6 and found to be negative postoperatively in the patient. The donor however had a dye test titre of 1/32 with Toxoplasma IgM of 1/16. On the 12th postoperative day the patient's dye test titre was 1/64 Toxoplasma IgM 1/32. Sera from the six blood donors involved was also tested for Toxoplasma antibody. Only two of these were positive and those only to a titre of 1/16. No Toxoplasma IgM was present.
Pretransplant sera from 41 cardiac recipients were tested for Toxoplasma antibodies using the Latex test; of these 16 were positive (39%). Sera from 30 heart donors were tested likewise and 11 were positive (37%). Of 24 matched donor-recipient pairs only four instances of a positive donor.h.eart put iuto a negative recipient occurred. Two of these developed toxoplasmosis, although Toxoplasma was not isolated from the second case, the third died eight days postoperatively from acute rejection and the fourth is alive and well. Discussion
Immunosuppressed transplant patients are at increased risk of infection. The organisms encountered during the course of the Stanford heart transplant programme have been listed in Jamieson et al.' Among these patients were eight who developed Toxoplasma infection seven of whom died. In two of these cases4 evidence was produced that the organisms were conveyed in the donated heart. This evidence consisted of the signs of infection in the perioperative period in recipients without serological evidence of previous Toxoplasma exposure. These authors thought that it was very unlikely that the toxoplasma infection was acquired from the hospital environment or from transfused blood.
In our case-the serological evidence indicates that the donor but not the recipient had experienced previous Toxoplasma infection and that the blood donors had no evidence of active or developing Toxoplasma-infection at the time of the blood collections.-Besides assessing the presence and degree of rejection myocardial biopsy may also show the presence of infecting organisms4 5 and Billingham mentions that cytomegalovirus, coccidiomyocosis, fungi and Toxoplasma have all been diagnosed on routine endomyocardial biopsy. In our case routine enfdomyocardial biopsy showed the presence of the Toxoplasma parasites and helped to explain the patient's fever.
It is difficult to diagnose the infection without frequent antibody tests and the available drugs are of limited value in controlling the infection. In our patient anti-Toxoplasma chemotherapy had to be abandoned because of the marked deterioration in renal function.
Possibly a vaccine would be effective but it would need to be shown to be protective in heart transplant patients where a Toxoplasma infected donor heart was supplied to the recipient. The overall prevalence of Toxoplasma organisms in donor hearts remains unknown. We would like to acknowledge the technical help of Mrs Marjorie Perkins.
